YOQNEAM, Israel, Oct. 10, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it will release its results for the third quarter of 2019 before the Nasdaq market opens on Tuesday, November 5, 2019.

SALT LAKE CITY, Oct. 10, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), clinical-stage biopharmaceutical company, announced today that Dr. Mahesh Patel, Chairman,

REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 10, 2019 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) ("Foamix" or the "Company"), a clinical stage specialty pharmaceutical company, today announced it will present results from nine clinical trials in five posters relating to its investigational topical product candidates FMX101

SAN MARCOS, Calif., Oct. 10, 2019 /PRNewswire/ -- PACE®, which stands for Program of All-inclusive Care for the Elderly, has come to north San Diego County with the official ribbon-cutting today of the nonprofit

MISSOULA, Mont., Oct. 10, 2019 /PRNewswire/ -- FYR Diagnostics LLC, a privately held, Montana-based company focused on developing novel diagnostic technologies, today announced that the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded the company

$10,000 Scholarships Awarded to Nine Students Affected by Dermatologic Conditions LAVAL, Quebec, Oct. 10, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the 2019 Aspire Highe

DALLAS, Oct. 10, 2019 /PRNewswire/ -- Phynd Technologies, a leading provider information management vendor, announced today a partnership with

DENVER, Oct. 10, 2019 /PRNewswire/ -- Radiology Imaging Associates, PC will welcome 20 physicians from Rocky Mountain Radiologists, PC to the RIA practice on January 1, 2020. "The two practices are naturally compatible," said Andrew Fisher, MD, MBA, member of the RIA Board of Directors, and director of t

DUBLIN, Oct. 10, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced a national education campaign called My Glaucoma. The campaign is designed to help people understand the burden of living with glaucoma and empower those with the disease and their caregivers to fe

DUBLIN, Oct. 10, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced a national education campaign called My Glaucoma. The campaign is designed to help people understand the burden of living with glaucoma and empower those with the disease and their caregivers to fe